Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: Harold who wrote (2022)	2/5/1998 9:02:00 AM
From: rustyjack	Respond to of 3369

I have just sent an E-mail asking for clarification of this discrepancy. Maybe someone can phone them for a quicker response. I've lost too much already on my SALV investment. Can't afford the phone call :>(

To: Harold who wrote (2022)	2/5/1998 4:17:00 PM
From: rustyjack	Read Replies (2) \| Respond to of 3369

Sero-strip is approved for sale in India. I just received a call from Paul Slowey at SDS. The press release was in error as to India approval. Hema-strip is in clinical approvals while Sero-Strip is approved for sale and selling very well. I suggested he include this correction in the upcoming press release. I was surprised by the quick response.Perhaps they are making an effort to appease shareholders prior to the proxy vote. I'm still against the terms of the split.